BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$4.16
-0.16 (-3.71%)
Open$4.21
Previous Close$4.32
Day High$4.40
Day Low$4.01
52W High$20.40
52W Low$3.68
Volume—
Avg Volume12.4K
Market Cap52.37M
P/E Ratio—
EPS$-17.14
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+495.7% upside
Current
$4.16
$4.16
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.36M | 5.82M | 6.86M |
| Net Income | -563,828 | -513,311 | -545,732 |
| Profit Margin | -8.9% | -8.8% | -8.0% |
| EBITDA | -665,396 | -604,117 | -725,268 |
| Free Cash Flow | -534,078 | -494,442 | -500,696 |
| Rev Growth | -7.7% | -7.5% | +13.8% |
| Debt/Equity | 0.28 | 0.30 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |